Rolf J. Sebaldt

MD, CM, FRCPC, FACP

Associate Clinical Professor, Division of Rheumatology and Division of Clinical Pharmacology & Toxicology, Department of Medicine and Clinical Epidemiology and Biostatistics

Co-founding Faculty Member, Centre for Evaluation of Medicines, Father Sean O'Sullivan Research Centre

Staff Rheumatologist, St. Joseph's Healthcare Hamilton


Director, Clinforma Data Systems & Project Management

President & CEO, Fig.P Software Incorporated

One James South, Suite 1000
Hamilton, Ontario L8P 4R5

905.522.3447 X5223
905.522.3448
rolf.sebaldt@figpsoft.com

 

Education and Professional Standing

Research Interests

Dr. Sebaldt's research pursuits include:

  1. designing and performing observational and interventional studies focused on evaluating and improving appropriate drug prescribing, increasing preventive care services delivery and reducing care gaps measured against evidence-based best practice in both primary care and specialist settings, and
  2. designing and implementing novel and scalable information technology-based solutions to improve clinical data capture from the point of routine clinical care, thereby enhancing the value and validity of broadly-based prospective longitudinal clinical data collection programs for a variety of scientific purposes.

The research team he leads at Clinforma serves as the project and data management centre for large-scale observational and interventional studies in therapeutic areas including osteoporosis, osteoarthritis, hypertension, hypercholesterolemia, psychiatry, venous thrombo-embolism, gastroenterology, dermatology, respirology, dementia, geriatric pharmacology, vaccination and cancer screening.

Selected Publications

2004

  1. Sawka AM, Adachi JD, Papaioannou A, Thabane L, Ioannidis G, Davison KS, Olszynski W, Brown JP, Hanley DA, Murray T, Josse R, Sebaldt RJ, Petrie A, Tenenhouse A, Goldsmith CH. Are there differences between men and women prescribed bisphosphonate therapy in Canadian subspecialty osteoporosis practices? J Rheumatol 2004; 31:1993-5.
  2. Sebaldt RJ, Petrie A, Goldsmith CH, Marentette M. Appropriateness of NSAID and coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario - results from the CANOAR study. Am J Managed Care 2004; 10:742-50.
  3. Barkun A, Sabbah S, Enns R, Armstrong D, Gregor J, Fedorak RN, Rahme E, Toubouti Y, Martel M, Chiba N, Fallone CA; RUGBE Investigators. The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting. Am J Gastroenterol. 2004;99:1238-46.

2005

  1. Holbrook A, Grootendorst P, Willison D, Goldsmith C, Sebaldt R, Keshavjee K, Gaebel K. Can current electronic systems meet drug safety and effectiveness requirements? AMIA Annu Symp Proc 2005;:335-9.
  2. Hamel ME, Sebaldt RJ, Siminoski K, Adachi JD, Papadimitropoulos E, Petrie A, Goldsmith CH. Influence of fracture history and bone mineral density testing on the treatment of osteoporosis in two non-academic community centers. Osteoporosis Int 2004; Nov.
  3. Greenberg JD, Bingham CO, Abramson SB, Reed G, Sebaldt RJ, Kremer J. Effect of cardiovascular comorbidities and concomitant aspirin use on selection of cyclooxygenase inhibitor among rheumatologists. Arthritis Rheum 2005; 53:12-7.
  4. Sawka AM, Ioannidis G, Papaioannou A, Thabane L, Olszynski WP, Brown JP, Hanley DA, Murray TM, Josse RG, Sebaldt RJ, Petrie A, Tenenhouse A, Goldsmith CH, Boulos P, Kouroukis T, Adachi JD. Are oral bisphosphonates effective in improving lumbar bone mineral density in breast cancer survivors with osteopenia or osteoporosis? J Obstet Gynaecol Can 2005; 27:759-64.
  5. Bensen R, Adachi JD, Papaioannou A, Ioannidis G, Olszynski WP, Sebaldt RJ, Murray TM, Josse RG, Brown JP, Hanley DA, Petrie A, Puglia M, Goldsmith CH, Bensen W. Evaluation of easily measured risk factors in the prediction of osteoporotic fractures. BMC Musculoskelet Disord. 2005; 6:47.
  6. Bourgault C, Davignon J, Fodor G, Gagne C, Gaudet D, Genest J, Lavoie MA, Leiter L, McPherson R, Senecal M, Marentette M, Sebaldt RJ. Statin therapy in Canadian patients with hypercholesterolemia: the Canadian Lipid Study -- Observational (CALIPSO). Can J Cardiol 2005; 21:1187-93.
  7. Bensoussan K, Fallone CA, Barkun AN, Martel M; RUGBE Investigators. A sampling of Canadian practice in managing nonvariceal upper gastrointestinal bleeding before recent guideline publication: is there room for improvement? Can J Gastroenterol. 2005;19:487-95.

2006

  1. Papaioannou A, Kennedy CC, Ioannidis G, Brown JP, Pathak A, Hanley DA, Josse RG, Sebaldt RJ, Olszynski WP, Tenenhouse A, Murray TM, Petrie A, Goldsmith CH, Adachi JD. Determinants of health-related quality of life in women with vertebral fractures. Osteoporos Int 2006; 17:355-63.
  2. Olszynski WP, Davison KS, Ioannidis G, Brown JP, Hanley DA, Josse RG, Murray TM, Papaioannou A, Sebaldt RJ, Tenenhouse AM, Petrie A, Goldsmith CH, Adachi JD. Effectiveness of alendronate and etidronate in the treatment of osteoporosis in men: a prospective observational study. Osteoporos Int 2006; 17:217-24.
  3. Kahn SR, Panju A, Geerts W, Pineo GF, Desjardins L, Turpie AGG, Glezer S, Thabane L, Sebaldt RJ. Multicenter Evaluation of the Use of Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients in Canada. Thrombosis Research 2006; March 1.
  4. Anderson KK, Sebaldt RJ, Lohfeld L, Burgess K, Donald FC, Kaczorowski J. Views of family physicians in southwestern Ontario on preventive care services and performance incentives. Family Practice 2006; 23:469-71.

Team Members

Project Manager: Annie Petrie, BSc
Data Manager: Allison Mark, BA
Systems Architect: David Beardwood, BMath
Database Programmer: Dan Vandermolen, BA
Project Coordinator: Yongning Ou, MD, BSc
Project Coordinator: Jenny Thompson, BComm
Software Programmer: Andrew Head, BSc
Software Programmer: Shirley Marshall, DiplT
Project Assistant: Ted Mark
Project Assistant: Maureen Petrie
Secretarial Assistant: Andrea Crawford